Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous group of malignant tumours that affects over 500,000 patients per year. Treatment failure is generally due to the heterogeneity of these tumours and to the serious adverse effects associated with treatment. Immunological system impairm...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaszczak, Wiktoria, Barczak, Wojciech, Wegner, Anna, Golusinski, Wojciech, Suchorska, Wiktoria Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357244/
https://www.ncbi.nlm.nih.gov/pubmed/28315228
http://dx.doi.org/10.1007/s12032-017-0918-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357244/
https://www.ncbi.nlm.nih.gov/pubmed/28315228
http://dx.doi.org/10.1007/s12032-017-0918-1

Ejemplares similares